X-18564526-GATATATATATAT-GATATATATAT
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001323289.2(CDKL5):c.145+27_145+28del variant causes a splice donor 5th base, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0538 in 556,775 control chromosomes in the GnomAD database, including 12 homozygotes. There are 400 hemizygotes in GnomAD. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 5 hom., 203 hem., cov: 19)
Exomes 𝑓: 0.063 ( 7 hom. 197 hem. )
Consequence
CDKL5
NM_001323289.2 splice_donor_5th_base, intron
NM_001323289.2 splice_donor_5th_base, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.405
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-18564526-GAT-G is Benign according to our data. Variant chrX-18564526-GAT-G is described in ClinVar as [Benign]. Clinvar id is 239511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-18564526-GAT-G is described in Lovd as [Benign]. Variant chrX-18564526-GAT-G is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0818 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.145+27_145+28del | splice_donor_5th_base_variant, intron_variant | ENST00000623535.2 | NP_001310218.1 | |||
CDKL5 | NM_001037343.2 | c.145+27_145+28del | splice_donor_5th_base_variant, intron_variant | NP_001032420.1 | ||||
CDKL5 | NM_003159.3 | c.145+27_145+28del | splice_donor_5th_base_variant, intron_variant | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.145+27_145+28del | splice_donor_5th_base_variant, intron_variant | 1 | NM_001323289.2 | ENSP00000485244 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 977AN: 93107Hom.: 5 Cov.: 19 AF XY: 0.00870 AC XY: 203AN XY: 23339
GnomAD3 genomes
AF:
AC:
977
AN:
93107
Hom.:
Cov.:
19
AF XY:
AC XY:
203
AN XY:
23339
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0643 AC: 4674AN: 72668Hom.: 0 AF XY: 0.000648 AC XY: 7AN XY: 10808
GnomAD3 exomes
AF:
AC:
4674
AN:
72668
Hom.:
AF XY:
AC XY:
7
AN XY:
10808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0625 AC: 29001AN: 463698Hom.: 7 AF XY: 0.00206 AC XY: 197AN XY: 95852
GnomAD4 exome
AF:
AC:
29001
AN:
463698
Hom.:
AF XY:
AC XY:
197
AN XY:
95852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0105 AC: 977AN: 93077Hom.: 5 Cov.: 19 AF XY: 0.00870 AC XY: 203AN XY: 23337
GnomAD4 genome
AF:
AC:
977
AN:
93077
Hom.:
Cov.:
19
AF XY:
AC XY:
203
AN XY:
23337
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 13, 2019 | - - |
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at